Histone Deacetylases (HDACs) as Key Targets in Metabolic Disorders
<p id="p1">Metabolic disorders such as obesity, diabetes, cardiac hypertrophy, and atherosclerosis are linked to changes in diet, exercise, aging, and genetics. Nonetheless, several studies propose that other environmental factors and epigenetic regulations may also contribute remarkably to the rapi...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2024
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/89244 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Histone Deacetylases (HDACs) as Key Targets in Metabolic Disorders
- Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties
- Lactobacillus as Epigenetic Architects: Butyrate-Driven HDAC Inhibition and Multiaxis Metabolic Reprogramming
- Histone Modification and Breast Cancer
- Key Role of Histone Modifiers in Coupling Metabolism to Epigenetic Reprogramming Associated with “Trained Immunity” in Innate Immune Cells
- Perspectives of Chitin Deacetylase Research
- Histone Acetyltransferases (HATs) Involved in Non-Homologous End Joining as a Target for Radiosensitization